Medico Remedies Limited (BOM:540937)
India · Delayed Price · Currency is INR | Market Cap | 3.49B -20.7% |
| Revenue (ttm) | 2.06B +36.7% |
| Net Income | 131.15M +29.9% |
| EPS | 1.58 +29.9% |
| Shares Out | 82.98M |
| PE Ratio | 26.65 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 12,074 |
| Open | 41.98 |
| Previous Close | 42.20 |
| Day's Range | 41.59 - 43.92 |
| 52-Week Range | 31.00 - 56.99 |
| Beta | 0.56 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 21, 2026 |
About Medico Remedies
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster... [Read more]
Financial Performance
In fiscal year 2026, Medico Remedies's revenue was 2.06 billion, an increase of 36.73% compared to the previous year's 1.51 billion. Earnings were 131.15 million, an increase of 29.94%.
Financial StatementsNews
Medico Remedies shares surge nearly 5% after winning $1.78 million order from Turkmenistan government
Shares of Medico Remedies Ltd jumped 4.91% to ₹51.50 in early Tuesday trade after the company announced securing a significant...